Erik Danielsen serves as Executive at NYMOX PHARMACEUTICAL CORP, where they oversee executive responsibilities. Since joining the company, Erik Danielsen has executed 2 insider transactions totaling $15.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 21, 2018 involved purchasing 6,000 shares valued at $8.1K.
Erik Danielsen currently holds 20,900 shares of NYMOX PHARMACEUTICAL CORP (NYMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erik Danielsen has been a net buyer of NYMX stock. They have purchased $15.8K and sold $0 worth of shares.
Erik Danielsen's most recent insider trade was on Dec 21, 2018, when they purchased 6,000 shares at $1.35 per share.
Get notified when new Form 4 filings are submitted
| $1.54 |
| Discretionary |